Company intelligence / Profile preview

Pioneera

Abu Dhabi, Abu Dhabi, United Arab Emiratespioneera.com ↗

Ownership: Private
Development stage: Commercial

Overview

Pioneera Biosciences is developing an AI-driven platform to accelerate the creation of next-generation CAR-T and CAR-NK therapies targeting cancer. The company aims to democratize access to advanced cell and gene therapies globally, with a particular emphasis on precision oncology. There are no reported clinical results or ongoing trials as of June 2025

Therapeutic areas: Oncology
Modalities: CAR-T cell therapyCAR-NK cell therapyCell therapyGene therapy
Industry: Biotech

Beyond the preview

Go deeper on Pioneera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pioneera.

Explore the full profile